VirTra Shines with Record-Breaking Revenue, Beam Global Beats Expectations, Eloxx Pharmaceuticals Misses Estimates, Ducommun Launches Public Offering
- May 15th, 2023
- 642 views
VirTra, Inc. (Nasdaq: VTSI) achieved remarkable double-digit millions in quarterly revenue for the first time, surpassing expectations with Q1 2023 earnings per share (EPS) of $0.27 compared to the consensus estimate of $0.04.
In after-hours trading, $VTSI is currently valued at $6.99, experiencing a notable increase of $1.07 (+18.07%).
Beam Global (Nasdaq: BEEM) reported a loss of $0.38 per share for the first quarter 2023, performing better than the consensus estimate of a loss of $0.42 per share.
$BEEM is trading at $11.69 in after-hours, reflecting a significant gain of $1.66 (+16.55%).
Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX) reported a loss of $2.88 per share for Q1 2023, worse than the consensus estimate of a loss of $2.55 per share.
In after-hours trading, $ELOX is currently valued at $8.23, experiencing a decline of $2.67 (-24.50%).
Ducommun Incorporated (NYSE: DCO) announced the launch of an underwritten public offering of 2,000,000 shares of its common stock.
Following this announcement, $DCO is trading at $43.75 in after-hours, indicating a decrease of $4.67 (-9.64%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
FTC Takes Action to Prevent Anticompetitive Arrangement in Beretta, Ruger Deal
September 16th, 2026Why Opponent Preparation Matters for Post-Graduate Athletes
September 16th, 2026The Work Behind the Game: How Football Teams Prepare to Compete
September 15th, 2026NJCP Operates on a Prep Model Built Around a Full Season
September 14th, 2026Earnings Preview: High Tide, Kestra Medical, and RF Industries in Focus
September 12th, 2026
Member Login